224 related articles for article (PubMed ID: 22102703)
21. Characteristics of CARMA1-BCL10-MALT1-A20-NF-κB expression in T cell-acute lymphocytic leukemia.
Ma Y; Liao Z; Xu Y; Zhong Z; Wang X; Zhang F; Chen S; Yang L; Luo G; Huang X; Huang S; Wu X; Li Y
Eur J Med Res; 2014 Nov; 19(1):62. PubMed ID: 25384343
[TBL] [Abstract][Full Text] [Related]
22. The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development.
Rossi D; Trifonov V; Fangazio M; Bruscaggin A; Rasi S; Spina V; Monti S; Vaisitti T; Arruga F; Famà R; Ciardullo C; Greco M; Cresta S; Piranda D; Holmes A; Fabbri G; Messina M; Rinaldi A; Wang J; Agostinelli C; Piccaluga PP; Lucioni M; Tabbò F; Serra R; Franceschetti S; Deambrogi C; Daniele G; Gattei V; Marasca R; Facchetti F; Arcaini L; Inghirami G; Bertoni F; Pileri SA; Deaglio S; Foà R; Dalla-Favera R; Pasqualucci L; Rabadan R; Gaidano G
J Exp Med; 2012 Aug; 209(9):1537-51. PubMed ID: 22891273
[TBL] [Abstract][Full Text] [Related]
23. MYD88, CARD11, and CD79B Oncogenic Mutations are Rare Events in the Indian Cohort of De Novo Nodal Diffuse Large B-Cell Lymphoma.
Aggarwal V; Das A; Bal A; Srinivasan R; Das R; Prakash G; Malhotra P; Varma S
Appl Immunohistochem Mol Morphol; 2019 Apr; 27(4):311-318. PubMed ID: 29734251
[TBL] [Abstract][Full Text] [Related]
24. Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphoma.
Rossi D; Deaglio S; Dominguez-Sola D; Rasi S; Vaisitti T; Agostinelli C; Spina V; Bruscaggin A; Monti S; Cerri M; Cresta S; Fangazio M; Arcaini L; Lucioni M; Marasca R; Thieblemont C; Capello D; Facchetti F; Kwee I; Pileri SA; Foà R; Bertoni F; Dalla-Favera R; Pasqualucci L; Gaidano G
Blood; 2011 Nov; 118(18):4930-4. PubMed ID: 21881048
[TBL] [Abstract][Full Text] [Related]
25. A20 deletion is associated with copy number gain at the TNFA/B/C locus and occurs preferentially in translocation-negative MALT lymphoma of the ocular adnexa and salivary glands.
Chanudet E; Ye H; Ferry J; Bacon CM; Adam P; Müller-Hermelink HK; Radford J; Pileri SA; Ichimura K; Collins VP; Hamoudi RA; Nicholson AG; Wotherspoon AC; Isaacson PG; Du MQ
J Pathol; 2009 Feb; 217(3):420-30. PubMed ID: 19006194
[TBL] [Abstract][Full Text] [Related]
26. Improved biological insight and influence on management in indolent lymphoma. Talk 3: update on nodal and splenic marginal zone lymphoma.
Thieblemont C
Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):371-378. PubMed ID: 29222281
[TBL] [Abstract][Full Text] [Related]
27. High-throughput sequencing analysis of the chromosome 7q32 deletion reveals IRF5 as a potential tumour suppressor in splenic marginal-zone lymphoma.
Fresquet V; Robles EF; Parker A; Martinez-Useros J; Mena M; Malumbres R; Agirre X; Catarino S; Arteta D; Osaba L; Mollejo M; Hernandez-Rivas JM; Calasanz MJ; Daibata M; Dyer MJ; Prosper F; Vizcarra E; Piris MÁ; Oscier D; Martinez-Climent JA
Br J Haematol; 2012 Sep; 158(6):712-26. PubMed ID: 22816737
[TBL] [Abstract][Full Text] [Related]
28. Adaptive T-cell immunity controls senescence-prone MyD88- or CARD11-mutant B-cell lymphomas.
Reimann M; Schrezenmeier J; Richter-Pechanska P; Dolnik A; Hick TP; Schleich K; Cai X; Fan DNY; Lohneis P; Maßwig S; Denker S; Busse A; Knittel G; Flümann R; Childs D; Childs L; Gätjens-Sanchez AM; Bullinger L; Rosenwald A; Reinhardt HC; Schmitt CA
Blood; 2021 May; 137(20):2785-2799. PubMed ID: 33232972
[TBL] [Abstract][Full Text] [Related]
29. Role of nuclear factor-κB regulators TNFAIP3 and CARD11 in Middle Eastern diffuse large B-cell lymphoma.
Bu R; Bavi P; Abubaker J; Jehan Z; Al-Haqawi W; Ajarim D; Al-Dayel F; Uddin S; Al-Kuraya KS
Leuk Lymphoma; 2012 Oct; 53(10):1971-7. PubMed ID: 22397314
[TBL] [Abstract][Full Text] [Related]
30. Differential expression of Toll-like receptor (TLR) and B cell receptor (BCR) signaling molecules in primary diffuse large B-cell lymphoma of the central nervous system.
Akhter A; Masir N; Elyamany G; Phang KC; Mahe E; Al-Zahrani AM; Shabani-Rad MT; Stewart DA; Mansoor A
J Neurooncol; 2015 Jan; 121(2):289-96. PubMed ID: 25391967
[TBL] [Abstract][Full Text] [Related]
31. Emu-BCL10 mice exhibit constitutive activation of both canonical and noncanonical NF-kappaB pathways generating marginal zone (MZ) B-cell expansion as a precursor to splenic MZ lymphoma.
Li Z; Wang H; Xue L; Shin DM; Roopenian D; Xu W; Qi CF; Sangster MY; Orihuela CJ; Tuomanen E; Rehg JE; Cui X; Zhang Q; Morse HC; Morris SW
Blood; 2009 Nov; 114(19):4158-68. PubMed ID: 19696203
[TBL] [Abstract][Full Text] [Related]
32. MYD88, CD79B, and CARD11 gene mutations in CD5-positive diffuse large B-cell lymphoma.
Takeuchi T; Yamaguchi M; Kobayashi K; Miyazaki K; Tawara I; Imai H; Ono R; Nosaka T; Tanaka K; Katayama N
Cancer; 2017 Apr; 123(7):1166-1173. PubMed ID: 27915469
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA losses in the frequently deleted region of 7q in SMZL.
Ruiz-Ballesteros E; Mollejo M; Mateo M; Algara P; Martínez P; Piris MA
Leukemia; 2007 Dec; 21(12):2547-9. PubMed ID: 17625607
[No Abstract] [Full Text] [Related]
34. TNFAIP3 is the target gene of chromosome band 6q23.3-q24.1 loss in ocular adnexal marginal zone B cell lymphoma.
Honma K; Tsuzuki S; Nakagawa M; Karnan S; Aizawa Y; Kim WS; Kim YD; Ko YH; Seto M
Genes Chromosomes Cancer; 2008 Jan; 47(1):1-7. PubMed ID: 17886247
[TBL] [Abstract][Full Text] [Related]
35. Methylation patterns in marginal zone lymphoma.
Arribas AJ; Bertoni F
Best Pract Res Clin Haematol; 2017; 30(1-2):24-31. PubMed ID: 28288713
[TBL] [Abstract][Full Text] [Related]
36. An integrated genomic and expression analysis of 7q deletion in splenic marginal zone lymphoma.
Watkins AJ; Hamoudi RA; Zeng N; Yan Q; Huang Y; Liu H; Zhang J; Braggio E; Fonseca R; de Leval L; Isaacson PG; Wotherspoon A; McPhail ED; Dogan A; Du MQ
PLoS One; 2012; 7(9):e44997. PubMed ID: 23028731
[TBL] [Abstract][Full Text] [Related]
37. Oncogenically active MYD88 mutations in human lymphoma.
Ngo VN; Young RM; Schmitz R; Jhavar S; Xiao W; Lim KH; Kohlhammer H; Xu W; Yang Y; Zhao H; Shaffer AL; Romesser P; Wright G; Powell J; Rosenwald A; Muller-Hermelink HK; Ott G; Gascoyne RD; Connors JM; Rimsza LM; Campo E; Jaffe ES; Delabie J; Smeland EB; Fisher RI; Braziel RM; Tubbs RR; Cook JR; Weisenburger DD; Chan WC; Staudt LM
Nature; 2011 Feb; 470(7332):115-9. PubMed ID: 21179087
[TBL] [Abstract][Full Text] [Related]
38. CD79B and MYD88 Mutations in Splenic Marginal Zone Lymphoma.
Trøen G; Warsame A; Delabie J
ISRN Oncol; 2013; 2013():252318. PubMed ID: 23378931
[TBL] [Abstract][Full Text] [Related]
39. Progression to large B-cell lymphoma in splenic marginal zone lymphoma: a description of a series of 12 cases.
Camacho FI; Mollejo M; Mateo MS; Algara P; Navas C; Hernández JM; Santoja C; Solé F; Sánchez-Beato M; Piris MA
Am J Surg Pathol; 2001 Oct; 25(10):1268-76. PubMed ID: 11688461
[TBL] [Abstract][Full Text] [Related]
40. Clinical and biological features of B-cell neoplasms with CDK6 translocations: an association with a subgroup of splenic marginal zone lymphomas displaying frequent CD5 expression, prolymphocytic cells, and TP53 abnormalities.
Gailllard B; Cornillet-Lefebvre P; Le QH; Maloum K; Pannetier M; Lecoq-Lafon C; Grange B; Jondreville L; Michaux L; Nadal N; Ittel A; Luquet I; Struski S; Lefebvre C; Gaillard JB; Lafage-Pochitaloff M; Balducci E; Penther D; Barin C; Collonge-Rame MA; Jimenez-Poquet M; Richebourg S; Lemaire P; Defasque S; Radford-Weiss I; Bidet A; Susin SA; Nguyen-Khac F; Chapiro E;
Br J Haematol; 2021 Apr; 193(1):72-82. PubMed ID: 33314017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
